Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells

Area of Science:

• Developmental toxicology
• Systems biology
• Transcriptomics

Background:

• Understanding transcriptome changes at different drug concentrations is vital for developmental toxicology.
• Valproic acid (VPA) is a drug with known developmental effects.

Purpose of the Study:

• To investigate the effects of eight VPA concentrations on human embryonic stem cell differentiation to neuroectoderm.
• To establish design principles for toxicogenomics studies using VPA as a model.

Main Methods:

• Exposure of human embryonic stem cells to VPA (25-1000 μM) during neuroectodermal differentiation.
• Transcriptome analysis to identify differentially regulated genes.
• Biostatistical and systems biology approaches including transcription factor binding site (TFBS) analysis, gene ontology (GO) profiler, and a teratogenicity index.

Main Results:

• A continuous increase in differentially regulated genes with increasing VPA concentration.
• Distinct transcriptome signatures differentiating tolerated, teratogenic, and cytotoxic VPA concentrations.
• Identification of VPA's mode of action signatures (protein acetylation, developmental changes, cell migration) within the teratogenic range.
• Cytotoxicity associated with catabolism and decreased cell cycle gene expression, not canonical stress indicators.
• Teratogenicity index effectively distinguished VPA's developmental toxicity from cytotoxicity.

Conclusions:

• The highest non-cytotoxic drug concentration is recommended for toxicogenomics studies to avoid misleading mode-of-action data.
• Transcriptome profiling combined with systems biology tools can differentiate drug effects and establish concentration-dependent toxicological principles.